SMTSahajanand Medical Technologies Ltd.
Sahajanand Medical Technologies to raise stake in US firm SNP Medical
- Mergers & acquisitions
- Medical devices
Reviewed byKeshav SehgalBlacklitt Research
Sahajanand Medical Technologies (NSE: SMT) has approved an investment by its wholly owned subsidiary, Sahajanand Medical Technologies Ireland, in SNP Medical Corp, a US medical device startup, it said in a filing on 05 Nov 2026. The acquisition cost is up to USD 7,80,000, paid in cash, and the subsidiary's stake would rise from 14.15% to up to 17.19%.
The investment in detail
The board approved the investment on 05 Nov 2026, at a meeting that ran from 3:00 PM to 4:43 PM IST. The filing says the acquisition is tentatively expected to be completed by 31 Mar 2027.
The company says the purpose is diversification of its product portfolio, within its existing main line of business. SNP Medical Corp is a medical device startup based in the US, incorporated in Delaware on 31 May 2022. Its revenue was USD 5,64,930 in 2023, USD 2,34,960 in 2024 and USD 3,00,000 in 2025, per the filing.
The filing classes the transaction as a related party transaction. Ms. Priyanka Cohen, a promoter and Non-Executive Director of the company, is a Director in SNP Medical Corp, and the company says the deal is at arm's length.
How it fits the company
The company's Q2 FY27 consolidated total income was ₹375.65 crore and net profit ₹26.47 crore, against a market value of ₹4,786 crore at the 05 Nov 2026 close. The filing does not give the rupee amount of the investment in the company's accounts.
What the investment means for Sahajanand Medical Technologies' shareholders
The step adds to a holding the subsidiary already has in a related party, and the cash cost is capped at USD 7,80,000. The filing does not say what the price per share will be, how the valuation was done, or whether the investment will affect the company's consolidated results.
The next dated step is completion, tentatively due by 31 Mar 2027.
At a glance
| Item | Detail |
|---|---|
| Subsidiary | Sahajanand Medical Technologies Ireland Limited (SMT Ireland) |
| Target | SNP Medical Corp, Delaware, incorporated 31 May 2022 |
| Acquisition cost | Up to USD 7,80,000, cash |
| Holding | 14.15% as on 30 Sep 2026, up to 17.19% after acquisition |
| Expected completion | By 31 Mar 2027 |
| Board approval | 05 Nov 2026 |
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.